Cen Guo

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Liquid Chromatography Tandem Mass Spectrometry

Induced Pluripotent Stem Cells

Top Venues

CPT: pharmacometrics & systems pharmacology

The Journal of pharmacology and experimental therapeutics

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Cen Guo, Kai H Liao, Meng Li, I-Ming Wang, M Naveed Shaik, Donghua Yin
PK/PD model-informed dose selection for oncology phase I expansion: Case study based on PF-06939999, a PRMT5 inhibitor. CPT: pharmacometrics & systems pharmacology (2022)
Omid Hamid, Alberto A Chiappori, John A Thompson, Toshihiko Doi, Siwen Hu-Lieskovan, Ferry A L M Eskens, Willeke Ros, Adi Diab, Jean-Philippe Spano, Naiyer A Rizvi, Jeffrey S Wasser, Eric Angevin, Patrick A Ott, Alison Forgie, Wenjing Yang, Cen Guo, Jeffrey Chou, Anthony B El-Khoueiry
First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors. Journal for immunotherapy of cancer 10 (10) (2022)
Katsuaki Ito, Noora Sjöstedt, Melina M Malinen, Cen Guo, Kim L R Brouwer
Hepatic Transporter Alterations by Nuclear Receptor Agonist T0901317 in Sandwich-Cultured Human Hepatocytes: Proteomic Analysis and PBPK Modeling to Evaluate Drug-Drug Interaction Risk. The Journal of pharmacology and experimental therapeutics 373 (2) (2020)